• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 425 filed by BlueRiver Acquisition Corp.

    7/18/24 4:15:46 PM ET
    $BLUA
    Blank Checks
    Finance
    Get the next $BLUA alert in real time by email
    425 1 ea0209637-8k425_blue.htm FORM 8-K

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): July 15, 2024

     

     

     

    BlueRiver Acquisition Corp.

    (Exact name of registrant as specified in its charter)

     

     

     

    Cayman Islands   001-39961   98-1577027
    (State or other jurisdiction of
    incorporation or organization)
      (Commission File Number)   (I.R.S. Employer
    Identification Number)

     

    250 West Nottingham Drive, Suite 400

    San Antonio, Texas

      78209
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (210) 832 3305

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Units, each consisting of one Class A ordinary share and one-third of a redeemable Warrant to acquire one Class A ordinary share   BLUA.U   NYSE American LLC
    Class A ordinary share, par value $0.0001 per share   BLUA   NYSE American LLC
    Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   BLUA.WS   NYSE American LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    On July 15, 2024, NYSE American LLC (“NYSE American”) announced that the staff of NYSE Regulation has determined to suspend trading in the Class A ordinary shares (NYSE American: BLUA) and units (NYSE American: BLUA.U) of BlueRiver Acquisition Corp. (the “Company”) from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company’s listed securities, which included Company’s Class A ordinary shares, units and redeemable warrants (collectively, “Securities”), and the Company appealed such delisting determination. On July 12, 2024, the Company withdrew its appeal.

     

    On July 3, 2024, the NYSE American suspended trading in the Company’s redeemable warrants as they were trading at an abnormally low selling price. On July 15, 2024, the NYSE American suspended trading in the Company’s Class A ordinary shares and units and delisted the Company’s Securities by filing a Form 25 with the Securities and Exchange Commission.

     

    The Company may submit an application to have its Securities quoted on the OTCQX Marketplace (“OTCQX”). The Company cannot provide any assurance that the Securities will commence or continue to trade on this market, whether broker-dealers will continue to provide public quotes of the Securities on this market, whether the trading volume of the Securities will be sufficient to provide for an efficient trading market or whether quotes for the Securities will continue on this market in the future.  

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or other similar expressions (or negative versions of such words or expressions) that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Company undertakes no duty to update these forward-looking statements.

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    BlueRiver Acquisition Corp.  
         
    By: /s/ John Gregg  
    Name: John Gregg  
    Title: Co-Chief Executive Officer  

     

    Dated: July 18, 2024

     

    Get the next $BLUA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLUA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BLUA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by BlueRiver Acquisition Corp.

      SC 13G/A - BlueRiver Acquisition Corp. (0001831006) (Subject)

      8/9/24 2:47:16 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by BlueRiver Acquisition Corp. (Amendment)

      SC 13G/A - BlueRiver Acquisition Corp. (0001831006) (Subject)

      5/10/24 4:21:54 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form SC 13G filed by BlueRiver Acquisition Corp.

      SC 13G - BlueRiver Acquisition Corp. (0001831006) (Subject)

      3/11/24 7:49:12 PM ET
      $BLUA
      Blank Checks
      Finance

    $BLUA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NYSE American to Suspend Trading in BlueRiver Acquisition Corp. (BLUA)

      NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to suspend trading in the Class A ordinary shares (NYSE:BLUA) and units (NYSE:BLUA) of BlueRiver Acquisition Corp. (the "Company") from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company's listed securities, which included Company's Class A ordinary shares, units and redeemable warrants (collectively, "Securities"), and the Company appealed such delisting determination. On July 3, 2024, the NYSE American suspended trading in the Company's redeemable warrants as they were trading at an a

      7/15/24 9:15:00 AM ET
      $BLUA
      Blank Checks
      Finance
    • BlueRiver Acquisition Corp. Receives Commencement of Delisting Notice From NYSE American; Announces Extension of Merger Agreement

      BlueRiver Acquisition Corp. (NYSE:BLUA) (the "Company") announces that, as disclosed in the Company's Current Report on Form 8-K filed on February 7, 2024 with the United States Securities and Exchange Commission, the Company received a letter from the NYSE American LLC ("NYSE American" or the "Exchange") on February 2, 2024, stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company's Common Stock, Units and Rights (collectively, the "Securities") pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offe

      2/7/24 5:58:00 PM ET
      $BLUA
      Blank Checks
      Finance
    • Spinal Stabilization Technologies, LLC, a Leading Developer and Manufacturer of Spinal Medical Devices, to be Publicly Listed through a Proposed Business Combination with BlueRiver Acquisition Corp.

      Spinal Stabilization Technologies is a pioneer in developing minimally invasive surgical treatments for specific types of lower back pain. It is targeting a promising market opportunity within the areas of Augmented Discectomy and Degenerative Disc Disease. In March 2021, the FDA granted the PerQdisc Nucleus Replacement System, the Company's leading product candidate, designation as a Breakthrough Device, potentially allowing for a more streamlined FDA review process and reduced regulatory costs. Proposed transaction represents a pre-money equity value of $240 million for Spinal Stabilization Technologies. Existing Spinal Stabilization Technologies shareholders will roll 100% o

      7/24/23 5:04:00 AM ET
      $BLUA
      Blank Checks
      Finance

    $BLUA
    SEC Filings

    See more
    • SEC Form 425 filed by BlueRiver Acquisition Corp.

      425 - BlueRiver Acquisition Corp. (0001831006) (Subject)

      8/6/24 4:54:23 PM ET
      $BLUA
      Blank Checks
      Finance
    • BlueRiver Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - BlueRiver Acquisition Corp. (0001831006) (Filer)

      8/6/24 4:51:44 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form DEF 14A filed by BlueRiver Acquisition Corp.

      DEF 14A - BlueRiver Acquisition Corp. (0001831006) (Filer)

      7/26/24 4:36:22 PM ET
      $BLUA
      Blank Checks
      Finance